PROTHIONAMIDE, 250mg, tab., blister

STD DORAPRON2T1

Valid Article

Former Code(s): DORAPRON2T- DORAZBD0319
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AD01
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

PROTHIONAMIDE

Therapeutic Action

Thionamide, bacteriostatic

Prothionamide and ethionamide belong to the same therapeutic group.

Indications

Drug-Resistant Tuberculosis (DR-TB), in combination with other TB medicines

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be taken with food and/or at bedtime to limit gastrointestinal disturbances.

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

The quantity to be ordered is calculated per tablet, not per blister.

Precautions for Use

Do not administer to patients with severe hepatic impairment.

May cause gastrointestinal disturbances.

Contraindicated during pregnancy.

Storage

Below 25ºC - Protect from sunlight